A detailed history of Trillium Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Trillium Asset Management, LLC holds 104,027 shares of EW stock, worth $7.05 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
104,027
Previous 108,212 3.87%
Holding current value
$7.05 Million
Previous $10 Million 31.33%
% of portfolio
0.17%
Previous 0.25%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$59.7 - $93.78 $249,844 - $392,469
-4,185 Reduced 3.87%
104,027 $6.86 Million
Q2 2024

Aug 07, 2024

SELL
$84.3 - $94.31 $214,880 - $240,396
-2,549 Reduced 2.3%
108,212 $10 Million
Q1 2024

May 09, 2024

BUY
$72.54 - $95.56 $37,648 - $49,595
519 Added 0.47%
110,761 $10.6 Million
Q4 2023

Feb 08, 2024

SELL
$61.71 - $77.76 $99,661 - $125,582
-1,615 Reduced 1.44%
110,242 $8.41 Million
Q3 2023

Nov 07, 2023

SELL
$69.28 - $93.38 $181,097 - $244,095
-2,614 Reduced 2.28%
111,857 $7.75 Million
Q2 2023

Aug 09, 2023

BUY
$81.41 - $94.33 $192,534 - $223,090
2,365 Added 2.11%
114,471 $10.8 Million
Q1 2023

May 08, 2023

BUY
$74.26 - $84.51 $2.34 Million - $2.66 Million
31,488 Added 39.06%
112,106 $9.27 Million
Q4 2022

Feb 07, 2023

SELL
$68.3 - $87.44 $257,149 - $329,211
-3,765 Reduced 4.46%
80,618 $6.01 Million
Q3 2022

Nov 09, 2022

SELL
$82.37 - $107.29 $82,781 - $107,826
-1,005 Reduced 1.18%
84,383 $6.97 Million
Q1 2022

May 04, 2022

SELL
$101.96 - $128.34 $20,595 - $25,924
-202 Reduced 0.24%
85,388 $10.1 Million
Q4 2021

Feb 08, 2022

BUY
$106.37 - $130.68 $151,045 - $185,565
1,420 Added 1.69%
85,590 $11.1 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $414,727 - $494,682
4,030 Added 5.03%
84,170 $9.53 Million
Q2 2021

Aug 06, 2021

BUY
$83.84 - $104.76 $210,689 - $263,261
2,513 Added 3.24%
80,140 $8.3 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $35,773 - $45,523
499 Added 0.65%
77,627 $7.08 Million
Q3 2020

Nov 09, 2020

BUY
$67.19 - $87.44 $47,503 - $61,820
707 Added 0.93%
77,128 $6.16 Million
Q2 2020

Aug 06, 2020

BUY
$57.54 - $76.95 $2.92 Million - $3.9 Million
50,734 Added 197.51%
76,421 $5.28 Million
Q4 2019

Feb 10, 2020

SELL
$71.7 - $82.09 $38,574 - $44,164
-538 Reduced 2.05%
25,687 $5.99 Million
Q3 2019

Nov 06, 2019

BUY
$61.55 - $75.43 $31,021 - $38,016
504 Added 1.96%
26,225 $5.77 Million
Q4 2018

Feb 08, 2019

SELL
$46.41 - $56.94 $5,708 - $7,003
-123 Reduced 0.48%
25,721 $3.94 Million
Q1 2018

May 09, 2018

SELL
$37.19 - $47.45 $111,570 - $142,350
-3,000 Reduced 10.4%
25,844 $3.61 Million
Q4 2017

Feb 01, 2018

SELL
$33.79 - $39.39 $288,836 - $336,705
-8,548 Reduced 22.86%
28,844 $3.25 Million
Q3 2017

Nov 02, 2017

BUY
$36.29 - $38.83 $1.36 Million - $1.45 Million
37,392
37,392 $4.09 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Trillium Asset Management, LLC Portfolio

Follow Trillium Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trillium Asset Management, LLC with notifications on news.